Minimally Invasive Biomarker for Asthma Disease Severity
NCT02225678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2016-05-17
Summary
Can a clinical test be developed that could help manage asthma symptoms?
Conditions
- Asthma
- Healthy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
James Lee, PhD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- United States
Study Locations
More Related Trials
-
Analysis of Blood-based Biomarkers of Asthma
NCT00917787 ·Status: COMPLETED
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation
NCT01631760 ·Status: WITHDRAWN
-
Airway Inflammation and Disease Burden in Asthmatic Smokers
NCT02833727 ·Status: UNKNOWN
-
Developing a Childhood Asthma Risk Passive Digital Marker
NCT05826561 ·Status: TERMINATED ·Phase: NA
-
Immune Interactions in Severe Asthma
NCT02566668 ·Status: COMPLETED
-
The Role of Biomarkers in the Occurrence and Development of Asthma
NCT05768399 ·Status: RECRUITING
-
Approach to Predict Steroid Sensitivity in Patients With Asthma
NCT00811278 ·Status: COMPLETED
-
Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma
NCT03610685 ·Status: COMPLETED ·Phase: PHASE4
-
This is a 6-month Observational Study. Patients Included Will be Those Referred With a Possible Diagnosis or an Established Diagnosis of Asthma. It Will Look at the Association of the Asthma Microbiome and Disease Characteristics, Severity and Treatment Response.
NCT06028204 ·Status: UNKNOWN
-
Individualizing Treatment for Asthma in Primary Care
NCT06272370 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation
NCT07011394 ·Status: RECRUITING
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
NCT06385236 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
NCT01334853 ·Status: COMPLETED
-
Clock Proteins as Prognostic Markers
NCT06302959 ·Status: TERMINATED
-
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects
NCT00331058 ·Status: TERMINATED ·Phase: PHASE1
-
Assessing the Use of Mobile Technology in Adult Asthma Patients
NCT03103880 ·Status: COMPLETED ·Phase: NA
-
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 ·Status: COMPLETED
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
Development of a Breath Analyzer for Asthma Screening
NCT00386737 ·Status: UNKNOWN
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING
-
The Development of a Screening Assay by LC-MS/MS to Monitor Adherence to Asthma Treatment
NCT03460106 ·Status: UNKNOWN
-
Does Asthma Phenotype Have Impact on Disease Control
NCT01978678 ·Status: COMPLETED